Canakinumab + Warfarin Interaction
Moderateinteraction on record
Description
Canakinumab may normalize CYP450 enzyme formation, potentially affecting warfarin metabolism. Therapeutic monitoring and dose adjustment may be needed.
Mechanism
Normalization of CYP450 enzyme formation due to IL-1 suppression
Source: NLP:canakinumab